Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their ...

Jeffrey Smith, who runs Starboard, pushed Pfizer's board on Thursday to set up a special committee to probe potential ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

Here are some of the major companies whose stocks moved on the week’s news.

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...

JPMorgan Chase, Wells Fargo and BlackRock reported strong quarterly results to kick off earnings season, but concerns linger ...

Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...

An errant email to Pfizer CEO Albert Bourla tipped off the executive to an activist investor campaign, Endpoints News’ Drew Armstrong and Max Bayer report. The Atlantic’s Nicholas Florko explores ...